Hepion Pharmaceuticals Files 2024 10-K
Ticker: CTRVP · Form: 10-K · Filed: Apr 8, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 10-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
Hepion Pharma filed its 2024 10-K. Check financials.
AI Summary
Hepion Pharmaceuticals, Inc. filed its 2024 10-K on April 8, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly ContraVir Pharmaceuticals, Inc., is focused on pharmaceutical preparations. Its principal executive offices are located at 399 Thornall Street, Edison, NJ.
Why It Matters
This filing provides a comprehensive overview of Hepion Pharmaceuticals' financial health and operational status for the fiscal year 2024, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Hepion faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-04-08 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Filer of the 10-K
- ContraVir Pharmaceuticals, Inc. (company) — Former name of Hepion Pharmaceuticals
- 2024-12-31 (date) — Fiscal year end
- 2025-04-08 (date) — Filing date
- 399 Thornall Street, Edison, NJ (location) — Business and mailing address
FAQ
What is Hepion Pharmaceuticals' primary business activity?
Hepion Pharmaceuticals, Inc. is primarily involved in the Pharmaceutical Preparations industry, SIC code 2834.
When did Hepion Pharmaceuticals change its name?
The company changed its name from ContraVir Pharmaceuticals, Inc. on August 6, 2013.
Where is Hepion Pharmaceuticals located?
Hepion Pharmaceuticals' business and mailing address is 399 Thornall Street, First Floor, Edison, NJ 08837.
What is the SEC file number for Hepion Pharmaceuticals?
The SEC file number for Hepion Pharmaceuticals is 001-36856.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 8, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).